NationalHealth Ministry Aware Of 'Some' Controversy Around Covaxin Supply To Brazil: Govt In Lok SabhaBY Outlook Web Bureau
NationalBharat Biotech To Supply 500 Million Covaxin Doses To Centre for Immunisation ProgrammeBY Outlook Web Desk
NationalSubmitted Documents To WHO For Covaxin’s Emergency Use Listing: Bharat BiotechBY Outlook Web Bureau
Making A DifferenceBrazil: SC Authorises Probe To Investigate President Bolsonaro’s Response To Covaxin DealBY Associated Press
NationalPhase Three Clinical Trial Concludes 77.8 Per Cent Effectiveness Of CovaxinBY Outlook Web Desk
Making A DifferenceFollowed Standard Approach For Contracts, Regulatory Approvals In Brazil: Bharat BiotechBY Outlook Web Bureau
Making A DifferenceExplained: Why Is The Brazil Government Under The Scanner For Its Covaxin Contract?BY Outlook Web Bureau
NationalSupply Of Covaxin At Rs 150 Per Dose To Centre Not Sustainable In Long Run: Bharat BiotechBY Outlook Web Bureau
NationalAmid Allegations Of ‘Selling Vaccines’, Punjab Govt Asks Private Hospitals To Return StockBY Outlook Web Bureau
NationalMore Information Required From Bharat Biotech For Emergency Use Listing Of Covaxin: WHOBY Outlook Web Bureau
NationalCovaxin Effective Against UK Strain And Covid Variant Found In India: Bharat BiotechBY Outlook Web Bureau
NationalBharat Biotech Says Can’t Give Additional Covaxin Doses to Delhi: Manish SisodiaBY Outlook Web Bureau
NationalCovaxin Is 78% Effective Against Mild To Severe Covid-19 Infections: Bharat BiotechBY Outlook Web Bureau
NationalBharat Biotech To Ramp Up Manufacturing Capacity, To Produce 700 Mn Doses Of Covaxin AnnuallyBY Outlook Web Bureau
NationalCovaxin Shows 81% Efficacy In Phase 3 Trials, Also Works Against Virus Variants: Bharat BiotechBY Outlook Web Bureau
NationalPM Modi, All CMs Likely To Get Covid Vaccine Shots In 2nd Phase Of Vaccination DriveBY Outlook Web Bureau
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
